Showing results (51-60 of 148) with videos related to
Sort By:
Pageof 15
Viruses|January 26, 2024
Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT TrialAnna L Schuldt, Henry Bern, Melanie Hart, et al.Psychological Medicine|July 25, 2023
Plasma biomarkers of neurodegeneration in mild cognitive impairment with Lewy bodiesCalum Alexander Hamilton, John O'Brien, Amanda Heslegrave, et al.Acta Neuropathologica|January 31, 2018
Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTDThomas G Moens, Sarah Mizielinska, Teresa Niccoli, et al.Nature Medicine|January 30, 2025
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infectionEugene P Duff, Henrik Zetterberg, Amanda Heslegrave, et al.Journal of Parkinson'S Disease|April 25, 2022
Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson's DiseaseLucy L Gibson, Thomas A Pollak, Amanda Heslegrave, et al.Disease Models & Mechanisms|May 10, 2018
Molecular biomarkers of Alzheimer's disease: progress and prospectsTammaryn Lashley, Jonathan M Schott, Philip Weston, et al.Brain : a Journal of Neurology|October 21, 2024
Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodesAdam Al-Diwani, Nicholas M Provine, Andrew Murchison, et al.Journal of Neuroinflammation|July 21, 2023
Alzheimer's disease-associated complement gene variants influence plasma complement protein levelsAurora Veteleanu, Joshua Stevenson-Hoare, Samuel Keat, et al.Journal of Neuroinflammation|March 19, 2020
Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndromePatrick Altmann, Desiree De Simoni, Alexandra Kaider, et al.Brain Communications|November 16, 2022
Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's diseaseAlexander J Lowe, Filipe B Rodrigues, Marzena Arridge, et al.Pageof 15